Ac Immune Sa
Clinical trials sponsored by Ac Immune Sa, explained in plain language.
-
New shot aims to slow Alzheimer's in people with down syndrome
Disease control Recruiting nowThis study tests an experimental treatment called ACI-24.060 in people with early Alzheimer's disease and in adults with Down syndrome who do not have dementia. The goal is to see if it is safe and can help the immune system clear harmful amyloid plaques from the brain. About 304…
Phase: PHASE1, PHASE2 • Sponsor: AC Immune SA • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New PET tracer could spot Parkinson's protein in the brain
Diagnosis Recruiting nowThis early-phase study tests whether a new PET tracer, [18F]ACI-15916, can safely and reliably detect harmful α-synuclein protein clumps in the brain. About 46 people—some healthy and some with suspected Parkinson's disease, multiple system atrophy, or Lewy body dementia—will rec…
Phase: EARLY_PHASE1 • Sponsor: AC Immune SA • Aim: Diagnosis
Last updated Jun 15, 2026 19:02 UTC
-
Healthy volunteers needed to test experimental brain drug
Knowledge-focused Recruiting nowThis early-stage study tests a new drug called ACI-19764 in 78 healthy adults aged 18 to 65. The goal is to check its safety, how the body handles it, and its effect on immune markers. Participants receive either the drug or a placebo, with some taking a single dose and others da…
Phase: PHASE1 • Sponsor: AC Immune SA • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC